PLRX Earnings

Quarterly EPS
$-0.95
Q3 2024
$-0.82
Q4 2024
$-0.92
Q1 2025
$-0.71
Q2 2025
$-0.43
Q3 2025
$-0.38
Q4 2025
$-0.32
Q1 2026
$-0.36
Q2 2026
Latest RevenueN/A
Latest Net Income-22371000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.360-22371000+49.3%
Q1 2026-$0.320-20040000+65.2%
Q4 2025-$0.380-23577000+53.7%
Q3 2025-$0.430-26301000+54.7%
Q2 2025-$0.710-43300000+22.8%
Q1 2025-$0.920-56166000-17.9%
Q4 2024-$0.820-49732000-18.8%
Q3 2024-$0.950-57763000-35.7%
Q2 2024-$0.920-55854000
Q1 2024-$0.780-46955000
Q4 2023-$0.690-41109000
Q3 2023-$0.700-41487000
Pliant Therapeutics (PLRX) — Earnings